Helixate FS is one of the first factor VIII products available in the U.
The beauty of Helixate FS is that the product has been purified to the point where patients infuse a purified Factor VIII molecule without the presence of albumin.
To provide dosing flexibility to healthcare professionals and people who are managing their hemophilia A, Helixate FS comes in a variety of dosage strengths: 250 IU, 500 IU, 1000 IU, 2000 IU and the new 3000 IU.
Helixate FS is a recombinant factor VIII product indicated to control and prevent bleeding episodes in adults and children with hemophilia A.
The most serious adverse reactions with Helixate FS are systemic hypersensitivity reactions and the development of high-titer inhibitors necessitating alternative treatments to antihemophilic factor.
Helixate FS is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including mouse or hamster proteins.
Combining Helixate FS with HeliTrax may be ideal for the active, growing teen with hemophilia A who needs more factor product," said Jill Leone, RN, CCRP, nurse consultant.
Helixate FS is packaged with the Mix2Vial, an easy-to-use, plastic, needle-free transfer device with a built-in filter.
Before the availability of Mix2Vial, the reconstitution of Helixate FS required the use of a double-ended transfer needle, which increased patients' and caregivers' risk of accidental needlesticks.
For more information about Helixate FS and Mix2Vial, please visit http://www.